CAV1 and breast carcinoma: Furthermore, it enhances the activity of the Cav-1/NF-κB/c-Myc pathway in both the transgenic MMTV-PyVT breast cancer spontaneous model and the zebrafish breast cancer xenotransplantation model, without any reported adverse effects (Zeng et al. 2018).